Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
LUPIN TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
LUPIN Mar-23 |
TEVA PHARMA Dec-13 |
LUPIN/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 799 | 3,486 | - | |
Low | Rs | 583 | 3,028 | - | |
Sales per share (Unadj.) | Rs | 365.8 | 2,000.5 | - | |
Earnings per share (Unadj.) | Rs | 9.8 | 125.0 | - | |
Cash flow per share (Unadj.) | Rs | 29.2 | 286.7 | - | |
Dividends per share (Unadj.) | Rs | 4.00 | 109.40 | - | |
Avg Dividend yield | % | 0.6 | 3.4 | 17.2% | |
Book value per share (Unadj.) | Rs | 270.7 | 2,222.2 | - | |
Shares outstanding (eoy) | m | 454.98 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.9 | 1.6 | 116.0% | |
Avg P/E ratio | x | 70.2 | 26.1 | 269.5% | |
P/CF ratio (eoy) | x | 23.7 | 11.4 | 208.3% | |
Price / Book Value ratio | x | 2.6 | 1.5 | 174.2% | |
Dividend payout | % | 40.7 | 87.5 | 46.4% | |
Avg Mkt Cap | Rs m | 314,381 | 2,761,843 | 11.4% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 30,872 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,744.4 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,357.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 166,417 | 1,696,422 | 9.8% | |
Other income | Rs m | 1,509 | 0 | - | |
Total revenues | Rs m | 167,926 | 1,696,422 | 9.9% | |
Gross profit | Rs m | 17,206 | 464,566 | 3.7% | |
Depreciation | Rs m | 8,807 | 137,123 | 6.4% | |
Interest | Rs m | 2,743 | 33,320 | 8.2% | |
Profit before tax | Rs m | 7,165 | 294,122 | 2.4% | |
Minority Interest | Rs m | 0 | 1,336 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -193,075 | -0.0% | |
Tax | Rs m | 2,688 | -3,591 | -74.9% | |
Profit after tax | Rs m | 4,477 | 105,974 | 4.2% | |
Gross profit margin | % | 10.3 | 27.4 | 37.8% | |
Effective tax rate | % | 37.5 | -1.2 | -3,072.8% | |
Net profit margin | % | 2.7 | 6.2 | 43.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 124,513 | 1,145,757 | 10.9% | |
Current liabilities | Rs m | 92,654 | 999,197 | 9.3% | |
Net working cap to sales | % | 19.1 | 8.6 | 221.6% | |
Current ratio | x | 1.3 | 1.1 | 117.2% | |
Inventory Days | Days | 26 | 91 | 28.9% | |
Debtors Days | Days | 98 | 96 | 102.5% | |
Net fixed assets | Rs m | 103,490 | 554,089 | 18.7% | |
Share capital | Rs m | 910 | 4,176 | 21.8% | |
Net worth | Rs m | 123,156 | 1,884,403 | 6.5% | |
Long term debt | Rs m | 275 | 867,418 | 0.0% | |
Total assets | Rs m | 228,003 | 3,876,868 | 5.9% | |
Interest coverage | x | 3.6 | 9.8 | 36.8% | |
Debt to equity ratio | x | 0 | 0.5 | 0.5% | |
Sales to assets ratio | x | 0.7 | 0.4 | 166.8% | |
Return on assets | % | 3.2 | 3.6 | 88.1% | |
Return on equity | % | 3.6 | 5.6 | 64.6% | |
Return on capital | % | 8.0 | 4.9 | 162.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 18,972 | 270,322 | 7.0% | |
From Investments | Rs m | -12,868 | -95,786 | 13.4% | |
From Financial Activity | Rs m | -3,373 | -324,269 | 1.0% | |
Net Cashflow | Rs m | 2,732 | -149,733 | -1.8% |
Compare LUPIN With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare LUPIN With: PLETHICO PHARMA KOPRAN. EVEREST ORGANICS NECTAR LIFESCIENCE SMS LIFESCIENCES INDIA
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.